Status:

COMPLETED

A Study to Evaluate the Efficacy of the Nasal Antiseptic, PrevinC, When Administered for the RiskReduction of Rhinitis in Subjects Who Work for Child Day Care Centers

Lead Sponsor:

BioHealth Technologies Inc.

Conditions:

Upper Respiratory Infections

Eligibility:

All Genders

18-65 years

Phase:

PHASE4

Brief Summary

The hypothesis was to establish whether the use of PrevinC administered nasally 2-3 times a day will prevent upper respiratory infections in otherwise healthy adults working in child day care centers.

Eligibility Criteria

Inclusion

  • Subject must provide written informed consent prior to the conduct of any study
  • Male or female
  • 18-65 years of age
  • Inclusive
  • Employed by one of seven selected Day Care Centers

Exclusion

  • Recent symptoms of upper respiratory infection, respiratory disease
  • Received medication for colds or allergies within 3 weeks of enrolling
  • Had nasal surgery within 2 months of enrolling
  • Had a pierced nose or wore nose jewelry

Key Trial Info

Start Date :

February 1 2005

Trial Type :

INTERVENTIONAL

End Date :

May 1 2005

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT02225912

Start Date

February 1 2005

End Date

May 1 2005

Last Update

January 16 2019

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Sunflower Preschool & Day Care

Hialeah, Florida, United States, 33010

2

Sunflower Preschool Childcare

Miami, Florida, United States, 33125

3

Sunflowers Academy

Miami, Florida, United States, 33125

4

Sunflowers Academy

Miami, Florida, United States, 33135

A Study to Evaluate the Efficacy of the Nasal Antiseptic, PrevinC, When Administered for the RiskReduction of Rhinitis in Subjects Who Work for Child Day Care Centers | DecenTrialz